These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18832479

  • 1. Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8.
    Fujiwara R, Nakajima M, Yamanaka H, Yokoi T.
    Drug Metab Dispos; 2009 Jan; 37(1):41-6. PubMed ID: 18832479
    [Abstract] [Full Text] [Related]

  • 2. In silico and in vitro approaches to elucidate the thermal stability of human UDP-glucuronosyltransferase (UGT) 1A9.
    Fujiwara R, Nakajima M, Yamamoto T, Nagao H, Yokoi T.
    Drug Metab Pharmacokinet; 2009 Jan; 24(3):235-44. PubMed ID: 19571435
    [Abstract] [Full Text] [Related]

  • 3. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
    Itäaho K, Laakkonen L, Finel M.
    Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
    [Abstract] [Full Text] [Related]

  • 4. Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone.
    Nishiyama T, Fujishima M, Masuda Y, Izawa T, Ohnuma T, Ogura K, Hiratsuka A.
    Arch Biochem Biophys; 2008 Oct 01; 478(1):75-80. PubMed ID: 18602884
    [Abstract] [Full Text] [Related]

  • 5. Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissues.
    Oda S, Nakajima M, Hatakeyama M, Fukami T, Yokoi T.
    Drug Metab Dispos; 2012 Aug 01; 40(8):1620-7. PubMed ID: 22619308
    [Abstract] [Full Text] [Related]

  • 6. Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8.
    Webb LJ, Miles KK, Auyeung DJ, Kessler FK, Ritter JK.
    Drug Metab Dispos; 2005 Jan 01; 33(1):77-82. PubMed ID: 15502008
    [Abstract] [Full Text] [Related]

  • 7. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O, Mackenzie PI, Bowalgaha K, Finel M, Miners JO.
    Drug Metab Dispos; 2009 Sep 01; 37(9):1948-55. PubMed ID: 19487247
    [Abstract] [Full Text] [Related]

  • 8. Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity.
    Korprasertthaworn P, Rowland A, Lewis BC, Mackenzie PI, Yoovathaworn K, Miners JO.
    Biochem Pharmacol; 2012 Dec 01; 84(11):1511-21. PubMed ID: 22981363
    [Abstract] [Full Text] [Related]

  • 9. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
    Senay C, Battaglia E, Chen G, Breton R, Fournel-Gigleux S, Magdalou J, Radominska-Pandya A.
    Arch Biochem Biophys; 1999 Aug 01; 368(1):75-84. PubMed ID: 10415114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
    Barre L, Fournel-Gigleux S, Finel M, Netter P, Magdalou J, Ouzzine M.
    FEBS J; 2007 Mar 01; 274(5):1256-64. PubMed ID: 17263731
    [Abstract] [Full Text] [Related]

  • 12. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG, Beaulieu M, Lévesque E, Hum DW, Bélanger A.
    J Mol Biol; 1999 May 28; 289(1):29-39. PubMed ID: 10339403
    [Abstract] [Full Text] [Related]

  • 13. Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
    Cheng Z, Radominska-Pandya A, Tephly TR.
    Drug Metab Dispos; 1999 Oct 28; 27(10):1165-70. PubMed ID: 10497143
    [Abstract] [Full Text] [Related]

  • 14. Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4.
    Bruck M, Li Q, Lamb JG, Tukey RH.
    Arch Biochem Biophys; 1997 Aug 15; 344(2):357-64. PubMed ID: 9264550
    [Abstract] [Full Text] [Related]

  • 15. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10).
    Martineau I, Tchernof A, Bélanger A.
    Drug Metab Dispos; 2004 Apr 15; 32(4):455-9. PubMed ID: 15039300
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.
    Strassburg CP, Manns MP, Tukey RH.
    J Biol Chem; 1998 Apr 10; 273(15):8719-26. PubMed ID: 9535849
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.